MT-6345

· Tanabe Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-6345, covering 2021-09-21 to 2021-09-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects [Phase 1]